Investigating Health, Equity, and Resilience in Girls and Women With ADHD Across the Lifespan
ConditionADHD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age10+
SponsorUniversity of Calgary
About this trial
The goal of this observational study is to generate a comprehensive, multi-dimensional dataset of health indicators collected from girls and women (aged 10 years and older) with and without ADHD across the lifespan. Participants will be asked to complete a detailed survey about hormonal and developmental life phases, ADHD status and symptoms, childhood experiences, health and well-being, and psychosocial outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Assigned female at birth or identify as girl or women
Fluency in English or French
Aged 10 years or older
Currently reside in Canada
Disqualifiers
Self-reported intellectual disability
Trial population
Recruitment will occur via multiple methods. Advertisements will be posted in communities across Canada (e.g., in medical clinics, ADHD clinics, community centres, etc.) via flyers and posters. In addition, recruitment materials will be posted online through social media posts (e.g., Instagram, Facebook, and LinkedIn), and University websites (e.g., The University of Calgary's 'Participate in Research' website). Potential participants will also be free to share recruitment information through their personal social media/email platforms or forward recruitment information to others, and study collaborators will disseminate recruitment information through their available channels and through community partner organizations. Lastly, eligible participants who have previously enrolled in our research studies and have consented to be contacted for future studies will be invited to participate.
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
No Intervention: Observational Cohort
Other interventionThis is an observational study with no intervention. Participants will only complete self-report questionnaires.
Treatment groups
1,460 Participants
are divided into 3 treatment groupsGroup A: Diagnosed ADHD1 intervention
Group B: Suspected ADHD1 intervention
Group C: Controls1 intervention
Trial outcomes
Primary outcomes
1
Self-reported mental health
Self-reported mental health history (assessed using a study-developed questionnaire querying current depression, anxiety, OCD, bipolar disorder, personality disorders, conduct disorder, oppositional defiant disorder, learning disorders, and other mental health challenges, as well as medication use for these conditions). This is a check list of disorders in which participants can self-identify diagnoses. There is no minimum/maximum.
Time frame
baseline (upon entry into study)2
Depression, anxiety, and stress
Depression, anxiety, and stress measured using the 18-item Depression Anxiety Stress Scales. Participants are asked to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week. Scores for Depression, Anxiety and Stress are calculated by summing the scores for the relevant items. Higher scores are indicative of greater distress.
Time frame
baseline (upon entry into study)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov